Multidose transdermal drug delivery system

Details Multidose transdermal drug delivery system Multidose transdermal drug delivery system

1997-12-08

1999-08-03

Brouillette, D. Gabrielle

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424448, 424489, 424490, 424493, A61F 1300

Patent

active

059322403

ABSTRACT:
A multidose transdermal drug delivery system comprises a laminate composite with a plurality of compartments. Each compartment is a reservoir for a unit dose of a drug active to be transdermally administered. The assembly is adhesively secured to the skin of a patient. Individual seals are provided for resealably enclosing the drug active in each of the reservoirs. The individual enclosing seals are removable to release the unit dose into contact with the skin of the patient and are actuable to control the transdermal absorption of the drug actives. Provisions are also made to automatically indicate the activation of the drug and to prevent an accidental release of medicament.

REFERENCES:
patent: 3161602 (1964-12-01), Herbig et al.
patent: 3270100 (1966-08-01), Jolkovski et al.
patent: 3336155 (1967-08-01), Rowe
patent: 3341466 (1967-09-01), Brynko et al.
patent: 3396117 (1968-08-01), Schuetze
patent: 3405070 (1968-10-01), Reyes
patent: 3567650 (1971-03-01), Bakan
patent: 3797494 (1974-03-01), Zaffaroni
patent: 3875074 (1975-04-01), Vassilades et al.
patent: 4145184 (1979-03-01), Brain et al.
patent: 4207315 (1980-06-01), Voorhees
patent: 4277364 (1981-07-01), Shasha et al.
patent: 4391909 (1983-07-01), Lim
patent: 4460368 (1984-07-01), Allison
patent: 4573996 (1986-03-01), Kwiatek
patent: 4666441 (1987-05-01), Andriola et al.
patent: 4708716 (1987-11-01), Sibalis
patent: 4743249 (1988-05-01), Loveland
patent: 4806355 (1989-02-01), Goosen et al.
patent: 4834978 (1989-05-01), Nuwayser
patent: 4904475 (1990-02-01), Gale
patent: 4913905 (1990-04-01), Fankhauser et al.
patent: 4917676 (1990-04-01), Heiber et al.
patent: 4917688 (1990-04-01), Nelson
patent: 5028435 (1991-07-01), Katz
patent: 5032403 (1991-07-01), Sinnreich
patent: 5042975 (1991-08-01), Chien et al.
patent: 5064422 (1991-11-01), Wick
patent: 5064654 (1991-11-01), Berner et al.
patent: 5071704 (1991-12-01), Fischel-Ghodsian
"Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat", (Soulis-Liporata et al.), Diabetes, vol. 40, Oct. 1991, pp. 1328-1334.
"Mechanistic Studies of Advanced Glycosylation and Product Inhibition by Aminoguanidine", (Edelstein et al), Diabetes, vol. 41, Jan. 1992, pp. 26-29.
"Effect of Aminoguanidine on Functional and Structural Abnormalities in Peripheral Nerve of STZ-Induced Diabetic Rats", (Yagihashi et al.), Diabetes, vol. 41, Jan. 1992, pp. 47-52.
"Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Disfunction", (Corbett et al.), Diabetes, vol. 41, Apr. 1992, pp. 552-556.
"Transdermal Delivery of Drugs", (Vaidyanathan et al.), vol. II, Chapter 5, pp. 63-83, published by CRL Press, Boca Raton, Florida; 1990.
"Transdermal Insulin Application in Type II Diabetic Patients", Arzneim.-Forsch./Drug Research 40 (II), No. 8, 1990--Insulin, pp. 880-883.
"Effects of Oral and Transdermal Insulin Applications on Blood Glucose Concentration of Mice", Arzneim.-Forsch./Drug Research 40 (II), No. 8, 1990--Insulin, pp. 884-886.

Affiliated with

Also associated with

Rating

Multidose transdermal drug delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multidose transdermal drug delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multidose transdermal drug delivery system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-847558